Document Detail

Incidence of arrhythmias after atrial or dual-chamber pacemaker implantation.
MedLine Citation:
PMID:  2924778     Owner:  NLM     Status:  MEDLINE    
The incidence of sustained atrial, pacemaker-mediated and ventricular rhythm disturbances was studied retrospectively in a consecutive series of 112 patients without a history of preexisting atrial tachyarrhythmias, receiving an atrial or dual-chamber pacemaker. Early atrial fibrillation (during the first week) was recorded twice. Late atrial fibrillation was seen in seven patients, flutter in one, yielding a total incidence of 8.9% for 22 months. There were no significant differences with respect to age, aetiology, electrocardiographic diagnosis, pacing history, or the measured intracardiac P wave between the group with and the group without atrial fibrillation. Treatment with digoxin reverted three patients to sinus rhythm, association of digoxin and amiodarone, six patients. One patient with congestive heart failure remained in atrial fibrillation. Pacemaker-mediated tachycardia was not a major problem. One patient of a subgroup with known ventricular arrhythmia had a non-sustained ventricular tachycardia during programming at follow-up; sustained ventricular tachycardia was not recorded. Reprogramming to VDD, DVI or VVI was done in 6/100 patients. The incidence of atrial fibrillation or flutter in highly selected patients with dual-chamber or atrial pacing is moderately low. It is not possible to identify patients with a high risk for development of atrial fibrillation; when it occurs, it is easily controlled with drugs. DDD pacing seems to be safe in patients with a history of serious ventricular arrhythmias, treated with appropriate drugs.
L Jordaens; E Robbens; E Van Wassenhove; D L Clement
Related Documents :
8077618 - Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in ...
3132008 - Long term evaluation of flecainide acetate in supraventricular tachyarrhythmias.
6621088 - Arrhythmias and conduction disturbances following cardiac operation for the removal of ...
9054758 - Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients unde...
588868 - Three weeks in isolation with two chronic schizophrenic patients.
11986248 - Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European heart journal     Volume:  10     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1989 Feb 
Date Detail:
Created Date:  1989-05-11     Completed Date:  1989-05-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  102-7     Citation Subset:  IM    
Department of Cardiology, University Hospital Ghent, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atrial Fibrillation / etiology*,  prevention & control
Heart Ventricles
Middle Aged
Pacemaker, Artificial* / adverse effects
Retrospective Studies
Tachycardia / etiology,  prevention & control

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  cDNA sequence of adrenodoxin reductase. Identification of NADP-binding sites in oxidoreductases.
Next Document:  The effect of respiration on diastolic blood flow velocities in the human heart.